LIFECORE BIOMEDICAL, INC. Assets Held-for-sale, Long Lived, Fair Value Disclosure
LIFECORE BIOMEDICAL, INC. (LFCR) had Assets Held-for-sale, Long Lived, Fair Value Disclosure of $0 as of 2020-11-29, per its 10-Q filed 2021-01-07.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:AssetsHeldForSaleLongLivedFairValueDisclosure · last filed 2021-01-07
- 2020-11-29: Assets Held-for-sale, Long Lived, Fair Value Disclosure $0.00.
- 2020-05-31: Assets Held-for-sale, Long Lived, Fair Value Disclosure $2.60M.
- 2020-02-23: Assets Held-for-sale, Long Lived, Fair Value Disclosure $2.60M.
| Period end | Assets Held-for-sale, Long Lived, Fair Value Disclosure |
|---|---|
| 2020-11-29 | $0.00 10-Q · filed 2021-01-07 |
| 2020-05-31 | $2.60M 10-Q · filed 2021-01-07 |
| 2020-02-23 | $2.60M 10-Q · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |